---
title: "Lakefront Biotherapeutics (LKFT.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/LKFT.US/norm.md"
symbol: "LKFT.US"
name: "Lakefront Biotherapeutics"
parent: "https://longbridge.com/en/quote/LKFT.US.md"
datetime: "2026-05-16T03:48:07.108Z"
locales:
  - [en](https://longbridge.com/en/quote/LKFT.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/LKFT.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/LKFT.US/norm.md)
---

# Lakefront Biotherapeutics (LKFT.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.2521 | 13.94 | -3.60 | -1.88 | -2.52 |
| ROE | 1.71% | 110.15% | -32.06% | -15.50% | -21.90% |
| Revenue | 7.43M | 1.06B | 83.45M | 76.42M | 81.16M |
| Net income | 16.61M | 918.66M | -237.02M | -123.78M | -166.06M |
| Operating income | -73.00M | 931.04M | -48.87M | -66.75M | -171.80M |
| Gross margin | -451.78% | 88.01% | -19.07% | -53.14% | -162.06% |
| Net margin | 223.61% | 86.83% | -284.02% | -161.97% | -204.60% |
| Profit quality | - | -1670.18% | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 3.86B | 4.00B | 4.12B | 4.47B | 4.35B |
| Leverage | 1.04 | 1.05 | 1.44 | 1.44 | 1.46 |
| BVPS | 56.58 | 57.68 | 43.55 | 46.96 | 45.18 |
| Turnover | 0.2823 | 0.2949 | 0.0747 | 0.0680 | 0.0688 |
| Cash & STI | 3.42B | 3.52B | 3.58B | 3.62B | 3.57B |
| Inv & Rec | 20.28M | 26.42M | 26.91M | 39.56M | 41.69M |
| LT assets | 88.18M | 94.74M | 123.86M | 128.39M | 122.56M |
| Net debt | -3.41B | -3.51B | -3.57B | -3.61B | -3.56B |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -94.83M | -55.74M | -73.42M | -127.33M | -41.79M |
| Investing CF | 70.48M | 85.30M | 66.54M | 87.45M | 91.74M |
| Financing CF | -584460.23 | -475687.10 | -1.47M | -702329.39 | -1.09M |
| Free CF | -102.36M | 440.72M | -72.60M | -14.97M | 48.44M |
| OCF coverage | -13072.67% | -2362.42% | -1524.40% | -2287.72% | -632.28% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -140958.06 | -1.88M | -3.34M | -4.86M | -5.52M |